Growth Metrics

Immuron (IMRN) Free Cash Flow (2016 - 2024)

Immuron's quarterly Free Cash Flow came in at -$2.6 million in Q4 2024, down 100.19% year-on-year from $1.3 billion in Q1 2024, and down 100.19% quarter-over-quarter from -$1.3 million in Q4 2023.

Immuron has reported Free Cash Flow for 7 years, with the latest figure at -$2.6 million in Q4 2024.

  • For the quarter ending Q4 2024, Free Cash Flow fell 100.19% year-over-year to -$2.6 million; the trailing twelve-month figure through Sep 2025 stood at -$2.6 million (down 100.19% YoY), and the FY2025 full-year result was -$3.1 million, up 47.27% from the prior year.
  • Free Cash Flow for Q4 2024 stood at -$2.6 million, down from -$1.3 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$1.3 million in Q4 2023, with the low at -$2.7 million in Q4 2020.
  • Average Free Cash Flow over 3 years is -$2.2 million, with a median of -$2.6 million recorded in 2024.
  • Year-over-year, Free Cash Flow sank 72.9% in 2020 and tumbled 100.19% in 2024.
  • Tracing IMRN's Free Cash Flow over 3 years: stood at -$2.7 million in 2020, then soared by 51.74% to -$1.3 million in 2023, then plunged by 100.19% to -$2.6 million in 2024.
  • The last three Free Cash Flow figures came in at -$2.6 million (Q4 2024), -$1.3 million (Q4 2023), and -$2.7 million (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.29 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 848.30 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67 Mn
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -2.61 Mn
Dec 31, 2024 -2.61 Mn
Dec 31, 2023 -1.30 Mn
Dec 31, 2023 -1.30 Mn
Dec 31, 2020 -2.70 Mn
Dec 31, 2020 -2.70 Mn
Dec 31, 2019 -1.56 Mn
Dec 31, 2019 -1.56 Mn
Dec 31, 2018 -424,940.00
Dec 31, 2018 -424,940.00
Dec 31, 2017 -2.48 Mn
Dec 31, 2017 -2.48 Mn
Dec 31, 2016 1.67 Mn
Dec 31, 2016 1.67 Mn